Pharmacokinetic analysis of erlotinib and OSI-420 in pediatric patients with malignant gliomas.

被引：0
|
作者：
Schaiquevich, P. [1 ]
Panetta, J. C. [1 ]
Throm, S. [1 ]
Bai, F. [1 ]
Broniscer, A. [1 ]
Stewart, C. [1 ]
机构：
[1] St Jude Childrens Hosp, Memphis, TN 38105 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [31] Malignant gliomas as second malignant neoplasms in pediatric oncological patients. One center experience
    Kobierska-Gulida, G.
    Izycka-Swieszewska, E.
    Stefanowicz, J.
    Drozynska, E.
    Niedzwiecki, M.
    Maciejka-Kapuscinska, L.
    Bien, E.
    Stachowicz-Stencel, T.
    Zaucha, R.
    Szurowska, E.
    Balcerska, A.
    VIRCHOWS ARCHIV, 2009, 455 : 160 - 161
  • [32] Phase II trial of bevacizumab plus erlotinib for patients with recurrent malignant gliomas: Final results.
    Sathornsumetee, S.
    Desjardins, A.
    Vredenburgh, J. J.
    McLendon, R. E.
    Marcello, J.
    Herndon, J. E.
    Norfleet, J.
    Gururangan, S.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
    Raizer, Jeffrey J.
    Abrey, Lauren E.
    Lassman, Andrew B.
    Chang, Susan M.
    Lamborn, Kathleen R.
    Kuhn, John G.
    Yung, W. K. Alfred
    Gilbert, Mark R.
    Aldape, Kenneth A.
    Wen, Patrick Y.
    Fine, Howard A.
    Mehta, Minesh
    DeAngelis, Lisa M.
    Lieberman, Frank
    Cloughesy, Timothy F.
    Robins, H. Ian
    Dancey, Janet
    Prados, Michael D.
    NEURO-ONCOLOGY, 2010, 12 (01) : 95 - 103
  • [34] A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
    Raizer, Jeffrey J.
    Abrey, Lauren E.
    Lassman, Andrew B.
    Chang, Susan M.
    Lamborn, Kathleen R.
    Kuhn, John G.
    Yung, W. K. Alfred
    Gilbert, Mark R.
    Aldape, Kenneth D.
    Wen, Patrick Y.
    Fine, Howard A.
    Mehta, Minesh
    DeAngelis, Lisa M.
    Lieberman, Frank
    Cloughesy, Timothy F.
    Robins, H. Ian
    Dancey, Janet
    Prados, Michael D.
    NEURO-ONCOLOGY, 2010, 12 (01) : 87 - 94
  • [35] A dose escalation (DE), pharmacokinetic (PK), and pharmacodynamic (PD) study of OSI-930 and erlotinib (E) in patients (pts) with advanced solid tumors
    Macpherson, I.
    Stewart, K.
    Chick, J.
    Brock, K.
    Poondru, S.
    Gedrich, R.
    Stephens, A. W.
    Evans, T. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] ANALYSIS OF FACTORS INFLUENCING SURVIVAL OF PATIENTS WITH ENDOCRANIAL MALIGNANT GLIOMAS
    KNERICH, R
    NICOLATO, A
    ADINOLFI, D
    GIUNTA, F
    SOFFIETI, R
    BUTTI, G
    BUONCRISTIANI
    ACTA NEUROCHIRURGICA, 1981, 57 (3-4) : 305 - 305
  • [37] Population pharmacokinetic analysis of atomoxetine in pediatric patients.
    Witcher, J
    Kurtz, D
    Heathman, M
    Sauer, J
    Smith, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P46 - P46
  • [38] Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients
    Poweleit, Ethan A.
    Taylor, Zachary L.
    Mizuno, Tomoyuki
    Vaughn, Samuel E.
    Desta, Zeruesenay
    Strawn, Jeffrey R.
    Ramsey, Laura B.
    CLINICAL PHARMACOKINETICS, 2023, 62 (11) : 1621 - 1637
  • [39] Population pharmacokinetic analysis of topotecan in pediatric cancer patients
    Schaiquevich, Paula
    Panetta, John C.
    Iacono, Lisa C.
    Freeman, Burgess B., III
    Santana, Victor M.
    Gajjar, Amar
    Stewart, Clinton F.
    CLINICAL CANCER RESEARCH, 2007, 13 (22) : 6703 - 6711
  • [40] Population pharmacokinetic analysis of fexofenadine in Japanese pediatric patients
    Martinez, Jean-Marie
    Khier, Sonia
    Morita, Shigemichi
    Rauch, Clemence
    Fabre, David
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 (02) : 187 - 195
12345